View publication

We develop a new model of insulin-glucose dynamics for forecasting blood glucose in type 1 diabetics. We augment an existing biomedical model by introducing time-varying dynamics driven by a machine learning sequence model. Our model maintains a physiologically plausible inductive bias and clinically interpretable parameters — e.g., insulin sensitivity — while inheriting the flexibility of modern pattern recognition algorithms. Critical to modeling success are the flexible, but structured representations of subject variability with a sequence model. In contrast, less constrained models like the LSTM fail to provide reliable or physiologically plausible forecasts. We conduct an extensive empirical study. We show that allowing biomedical model dynamics to vary in time improves forecasting at long time horizons, up to six hours, and produces forecasts consistent with the physiological effects of insulin and carbohydrates.

Related readings and updates.

We introduce TopoPrimer, a framework that makes the global topological structure of the series population an explicit input to any forecasting model. TopoPrimer improves accuracy across diverse domains, stabilizes forecasts under seasonal demand spikes, and closes the cold-start gap. Precomputed once per domain via persistent homology and spectral sheaf coordinates, TopoPrimer deploys per token for fully-trained models and as a lightweight…

Read more

Smart wearables enable continuous tracking of established biomarkers such as heart rate, heart rate variability, and blood oxygen saturation via photoplethysmography (PPG). Beyond these metrics, PPG waveforms contain richer physiological information, as recent deep learning (DL) studies demonstrate. However, DL models often rely on features with unclear physiological meaning, creating a tension between predictive power, clinical interpretability,…

Read more